SEO for online pharmacies: what you can say, what you cannot and what works

Why is pharmacy SEO different from normal e-commerce SEO?

Pharmacy SEO operates inside three stacked rule systems that ordinary retail never meets. The first is law: the Human Medicines Regulations 2012 prohibit advertising prescription-only medicines (POMs) to the public, which removes the standard e-commerce playbook of product pages, offers and paid promotion for a pharmacy's highest-value lines. The second is platform policy: Google restricts the promotion of prescription drug services to certified advertisers and treats violations as egregious, meaning permanent account suspension. The third is algorithmic: pharmacy content sits in Google's Your Money or Your Life (YMYL) category, where trust signals carry maximum weight in organic ranking.

The strategic consequence is that organic trust is the primary growth engine, not a nice-to-have. Salience's 2026 UK Online Pharmacy Index, tracking 344 brands, found sector organic traffic grew 15% in the year to March 2026, with the growth concentrated in mid-market operators whose review volume, clinical authorship and condition content compounded, while several household names declined. The winners did not find a way around the constraints. They built precisely the assets the constraints leave available, and this guide is essentially a description of that build.

What can a pharmacy legally say online?

A pharmacy can advertise itself, its services, its prices for those services and its non-prescription products, and it can publish health information freely, which together is a far larger content territory than most owners assume. The lawful map runs as follows. The pharmacy and its credentials: who you are, your General Pharmaceutical Council (GPhC) registration number linked to the register, your superintendent and prescribers with their registrations, which in Great Britain is now the trust display that matters since the GPhC's voluntary internet logo scheme closed on 31 December 2025. Services and pathways: a weight management clinic, a travel health service, a private consultation offer, described by what the service does, who it is for and what the consultation costs. Condition information: symptoms, causes, treatment categories and when to seek help, which is the entire foundation of content SEO and entirely lawful when accurate and balanced.

General sale and pharmacy (P) medicines may be advertised to the public, subject to the CAP Code's medicines section and the requirements set out in the MHRA's advertising guidance, which include presenting required product information accurately, not encouraging excessive use and carrying the familiar instruction to read the label. Price transparency for prescription services is lawful when handled inside the clinical journey: a consultation fee on a service page is advertising the service, while a named POM with a price on a landing page is advertising the medicine, and the whole compliance question often turns on exactly that distinction.

What can a pharmacy not say?

A pharmacy cannot promote prescription-only medicines to the public, and the prohibition catches far more than banner adverts. Naming a POM on a page structured to sell it, publishing POM price lists as offers, attaching discount codes to prescription medicines, bidding on branded drug terms, before-and-after imagery promoting prescription weight loss treatment and paying influencers to promote POMs are all within the prohibition, and all appear in the enforcement record. The Committee of Advertising Practice (CAP), the Medicines and Healthcare products Regulatory Agency (MHRA) and the GPhC issued a joint enforcement notice on advertising prescription-only weight management medicines in September 2025, covering online, social, email and print, and restated it in June 2026 with an added warning against promoting unlicensed pipeline medicines or running waiting lists for them. The Advertising Standards Authority operates AI-based monitoring, so non-compliant pages are found by machine rather than complaint.

The enforcement evidence says this is the sector's most common self-inflicted wound. The GPhC's April 2026 review found advertising behind 17% of all weight management concerns, with examples including POM names beside discount codes and paid TikTok promotion. Beyond the POM rules, the general law of misleading advertising still applies: no efficacy claims beyond the licence, no treatment guarantees, no testimonials that imply outcomes for prescription treatment. The safe editorial line for every page is the one we use in our own builds: market the service and the condition pathway, never the molecule. Written that way, pages convert perfectly well, and they are also, not coincidentally, the pages Google's trust systems prefer.

Can pharmacies run Google Ads?

Yes, within a certified and narrow lane, and the lane is narrower than most agencies realise. Google restricts the promotion of prescription drug services, which includes online pharmacies and telemedicine providers, to advertisers certified by Google, and certification requires registration with the relevant national authority, the GPhC for the UK. Shopping listings additionally require third-party accreditation, with LegitScript the programme Google's Merchant Center policy names for pharmacy certification. What certification buys in the UK is the right to promote the pharmacy and permitted products and services; it does not buy the right to use prescription drug terms promotionally in ad text or landing pages, which Google does not allow for UK-targeted campaigns. An October 2025 policy update relaxed this only for genuinely non-promotional contexts, and keyword targeting of drug terms still requires certification that UK campaigns cannot obtain for promotional use.

Two warnings from the recent record. First, Google classes violations of its pharmacy policies as egregious: accounts are suspended without prior warning and are generally not reinstated, so an agency experiment with branded drug keywords can end a pharmacy's paid channel permanently. Second, platform policy moves without your consent: in March 2026 Google ended the cross-border programme that let UK-certified pharmacies serve Shopping ads into Germany and Austria, closing a revenue channel some operators had built real volume on. Paid search for pharmacies is a legitimate, useful, conditional channel for permitted lines and service awareness. It is not a foundation, which returns us to the channel that is.

What actually works: the organic playbook

The organic playbook that the 2026 data validates has four components, and none of them is a trick. First, condition-led content architecture: pages organised around the problems people search, symptoms, causes, options, when to see a clinician, each connecting naturally to the relevant service. This is simultaneously the compliant structure, since it markets pathways rather than products, and the highest-intent traffic in the category. Second, clinical authorship: content carrying the name, registration and photograph of a real pharmacist or prescriber, because expertise Google can attribute is a measurable YMYL input and because patients in a market with a documented fake-pharmacy problem check. Third, review infrastructure: volume and recency of genuine reviews, captured as an operational habit wired into fulfilment rather than a quarterly campaign, which Salience's analysis identifies as the clearest trust proxy separating the sector's winners from its decliners. Fourth, verification-forward service pages: registration numbers, named clinicians, honest descriptions of the assessment process, which convert wary visitors precisely because most competitors hide the clinical reality.

The honest timeline is quarters, not weeks. Organic trust compounds: the mid-market pharmacies that grew 127% and 210% in the year to March 2026 were harvesting content and review assets built over prior years. That is the strongest argument for starting the build now and the strongest argument against launching a template site and hoping to retrofit authority later, a failure mode we covered in why most pharmacy websites fail.

Technical SEO for a pharmacy catalogue

Technical SEO for a pharmacy is mostly disciplined hygiene, with two category-specific judgements. The hygiene: a crawlable category architecture with clean URLs, fast pages that pass Core Web Vitals, canonical handling for product variants, and index management that keeps thin or duplicate catalogue pages out of Google's index rather than diluting the domain with 2,000 near-identical pages. Metadata at catalogue scale is its own workload, unique titles and descriptions across thousands of products, and doing it properly is a rewriting project rather than a template formula, which is exactly the exercise our catalogue metadata case study documents.

The judgements: structured data and POM pages. Product schema with price and availability is valuable and appropriate on permitted retail lines, and FAQPage schema on genuine questions supports both rich results and AI citation. But marking up prescription-only lines as purchasable products, with prices and offers in schema, publishes machine-readable promotional signals for medicines you cannot lawfully promote, so the conservative position we build to is simple: POM-related pages describe services, carry no product or offer markup and sit deliberately outside the e-commerce template.

AI search and being citable

Being cited by AI search engines rewards the same structure that answer-first SEO always has: pages that state a complete, accurate answer in the opening sentences, attribute claims to named sources and cover the real entities in the field, the GPhC, the MHRA, NHS services, rather than talking vaguely about regulators. Assistants and AI Overviews quote pages they can extract clean facts from, which is why every section of a well-built condition or service page should open with a sentence that survives being lifted out of context. Entity coverage also feeds the same trust assessment: content that demonstrates it knows how UK pharmacy actually works reads as expert to both algorithms and humans.

The honest caveat is that AI referral behaviour is still forming: citation drives visibility and brand searches more reliably than it yet drives measured clicks, so treat AI citability as an extension of the organic strategy rather than a separate channel with its own budget. The work is the same work.

A compliance sign-off process for marketing

Everything above collapses without one operational habit: nothing publishes until someone accountable has checked it against the rules, and in a pharmacy that person is ultimately the superintendent. The workable process is a one-page checklist applied to every new page, ad and social post: does it name a POM in a promotional context, does it price a POM as an offer, does it claim outcomes beyond the licence, does it promote anything unlicensed, does every P medicine advert carry the required information, does the page display registration details, and who approved it, dated. Ten minutes per asset, recorded, and it becomes part of the SOP set with an owner and a review trigger when guidance changes, exactly as our SOP guide describes.

This is not bureaucratic caution; it is the cheapest insurance in pharmacy marketing. The enforcement notice regime, ASA machine monitoring and the GPhC's demonstrated willingness to act on advertising mean a single non-compliant campaign can cost a paid account permanently and put the premises on the regulator's radar. A sign-off habit costs minutes. The alternative costs channels.

Key takeaways

FAQs